Overview

Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
Determination of progression free survival after 12 months of FU Determination of total survival, response and quality of life
Phase:
Phase 3
Details
Lead Sponsor:
North Eastern German Society of Gynaecological Oncology
North Eastern Germany Society of Gynaecologic Oncology
Treatments:
Carboplatin
Topotecan